This gross mixture has big benefits for the study of bacteria

Growing bacteria on agar mixed with organs is an efficient and effective way to study infectious pathogens

3:04 PM

Author | Kelly Malcom

sketched out bacteria in a dish yellow and blue colors of U-M
Credit: Jacob Dwyer, Justine Ross, Michigan Medicine

Animal models are a necessary research tool for understanding how diseases develop and how therapies work in biological systems and can be credited for breakthroughs ranging from effective antibiotics to the COVID vaccines.

The responsible and judicious use of animal models is prioritized by research institutions around the world and a unique research protocol developed by Melanie Pearson, Ph.D., of the Department of Microbiology & Immunology, and her team at University of Michigan Medical School is garnering widespread interest among microbiologists.

In a recent paper in the journal Infection and Immunity, her group describes a product called organ agar that could be deployed to more efficiently screen bacteria that cause urinary tract infections.

Agar is a gelatinous product made of seaweed routinely used in laboratories to grow colonies of bacteria in petri dishes.

Pearson discovered that creating a mixture composed of the agar plus human urine and the organ her team wanted to study, specifically the bladder and kidneys, enabled their team to screen more than 1,700 mutants of the UTI-causing bacteria Proteus mirabilis using a quarter of the mice typically required.

Pearson explains that in a classic mouse study of a urinary tract infection, mutated bacteria—bacteria that are missing individual genes— are introduced into an animal’s bladder and then the dominant strains assessed to determine what bacterial genes are important for infection. Knowing this could enable researchers to target specific variants for drug development, for example.

The use of organ agar has multiple potential benefits, explains Pearson.

For one, it can help microbiologists get around what is known as the bottleneck problem.

In a living system, only a certain number of mutants are able to gain a foothold, with the rest lost at random.

When Pearson tried the screening method using organ agar, her team found that the dominant bacteria reproduced those that were dominant in a live animal.

What’s more, bacteria that did not do well on organ agar also did not do well in a live animal.

Furthermore, organ agar could enable researchers without access to animal models to create physiologically relevant models of infection or colonization and allow for more efficient screening of bacterial and other microorganism candidates for further study.

Paper cited: “Organ agar serves as physiologically relevant alternative for in vivo bacterial colonization,” Infection and Immunity. DOI: 10.1128/iai.00355-23.


More Articles About: infectious disease All Research Topics Community Health Hospitals & Centers Vaccines and Immunizations
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories green background with white drawing of doctor at patient beside having conversation
Health Lab
Have a seat, doctor: Study suggests eye level connection makes a difference in hospitals
When doctors sit at hospitalized patients’ bedsides, it can have a more positive impact than if they stand, a review of data suggests – but a new study seeks to find out for sure.
bottle cap red
Health Lab
Bipolar disorder and alcohol: It’s not as simple as 'self-medication'
People with bipolar disorder have a high risk of alcohol use issues, which have been seen as “self medication,” but a study shows that changes in drinking predict worse symptoms.
iv chemo bags
Health Lab
Drug-chemo combo increases cancer treatment efficacy
A study finds giving a fatty acid inhibitor alongside chemotherapy could improve the treatment efficacy for patients with brain metastases from triple negative breast cancer
white coats hanging and one swinging off hanger with purple haze over them and sunshine peeking through
Health Lab
Who feels ready for residency?
Helen Morgan, M.D., of Michigan Medicine, authored a study that surveyed obstetric and gynecology residents to determine who feels prepared for the transition from medical school to residency.
close up photo of yellow pills lined up on a bright blue matt
Health Lab
New drug candidate blocks resistance to cancer therapies
A team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling mediated by two key drivers of cancer therapy resistance.
two women, one older one younger, looking concerned listening to a provider across from them with back to camera
Health Lab
Many breast cancer survivors don't receive genetic testing, despite being eligible
As cancer treatment and survivorship care relies more on understanding the genetic make up of an individual’s tumor, a study from the University of Michigan Health Rogel Cancer Center finds that many breast cancer survivors who meet criteria for genetic counseling and testing are not receiving it.